2010
DOI: 10.1371/journal.ppat.1000762
|View full text |Cite
|
Sign up to set email alerts
|

The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule

Abstract: Hepatitis C virus (HCV), a major cause of chronic liver disease in humans, is the focus of intense research efforts worldwide. Yet structural data on the viral envelope glycoproteins E1 and E2 are scarce, in spite of their essential role in the viral life cycle. To obtain more information, we developed an efficient production system of recombinant E2 ectodomain (E2e), truncated immediately upstream its trans-membrane (TM) region, using Drosophila melanogaster cells. This system yields a majority of monomeric p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
275
2
1

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 217 publications
(292 citation statements)
references
References 46 publications
14
275
2
1
Order By: Relevance
“…Despite these difficulties, related viruses, easier to cultivate, for instance bovine viral diarrhoea virus, have been used as surrogate models [38]. Secondly, recombinant forms of the envelope glycoproteins were used to search for viral receptors [33,39] but also as probes for antibody screening or neutralization of binding assays [40,41], to study HCV-induced receptor signalling during entry [42], to delineate E2-receptor interacting surfaces [43,44], or to draw a theoretical model for E2 structure [45]. Most frequently a soluble form of E2 produced in mammalian or insect cells and capable of inhibiting HCV entry [46] is used.…”
Section: Overview On the Viral Entry Systemsmentioning
confidence: 99%
“…Despite these difficulties, related viruses, easier to cultivate, for instance bovine viral diarrhoea virus, have been used as surrogate models [38]. Secondly, recombinant forms of the envelope glycoproteins were used to search for viral receptors [33,39] but also as probes for antibody screening or neutralization of binding assays [40,41], to study HCV-induced receptor signalling during entry [42], to delineate E2-receptor interacting surfaces [43,44], or to draw a theoretical model for E2 structure [45]. Most frequently a soluble form of E2 produced in mammalian or insect cells and capable of inhibiting HCV entry [46] is used.…”
Section: Overview On the Viral Entry Systemsmentioning
confidence: 99%
“…29,30 By analogy to the related flaviviruses, it is assumed that E1 and E2 initially form heterodimers, but might rearrange into trimeric complexes required for entry. [31][32][33][34] The p7 protein, composed of two TM regions that are interconnected by a short cytoplasmic loop, 35 is a viroporin able to form hexa-and heptameric complexes serving as ion channels and required for virus assembly and release. 36,37 NS2 is a dimeric integral membrane protein, composed of two functionally and topologically distinct domains: a highly hydrophobic, N-terminal, membrane anchor domain and a C-terminal cysteine protease domain, which liberates the C-terminus of NS2 from NS3.…”
Section: Hcv Proteinsmentioning
confidence: 99%
“…Furthermore, E1E2 is the only candidate vaccine to demonstrate broad nAb responses from vaccinated human volunteers (38,39,41,42). Soluble forms of E2 can be produced from mammalian and insect cells (20,21,59,60), and rational vaccine design has been proposed based on E2 cross-neutralizing epitopes (19). However, it is important to note that cross-neutralizing epitopes that contain E1 and E2 residues, such as those recognized by the broadly neutralizing MAbs AR4A and AR5A (15), are not represented in soluble E2 proteins.…”
Section: Discussionmentioning
confidence: 99%